New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:11 EDTAMPEAmpio closes enrollment in OptimEyes study for presentation to FDA
Ampio Pharmaceuticals has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema - oral treatment with Optina. The present enrollment of over 355 patients provides an adequate power of 88%, which the company believes is more than sufficient for statistical evaluation. By reducing the patient sample size, the company expects data by Q4.
News For AMPE From The Last 14 Days
Check below for free stories on AMPE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
13:44 EDTAMPEAmpio August volatility elevated
Subscribe for More Information
July 30, 2014
08:10 EDTAMPEAmpio receives FDA approval for production of Ampion in new facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use